Study of Socio-aesthetic Cares Anxiety-Reducing Effects in Cancer Patients Receiving Chemotherapy

What this Trial Is About

This research aims to evaluate the impact of socio-aesthetic care on anxiety levels in cancer patients undergoing chemotherapy. The study focuses on patients receiving chemotherapy every 14 or 21 days for cancers such as lung, breast, digestive, colorectal, or gynecological types. The main purpose is to compare patients State Anxiety scores before treatment and after the third chemotherapy cycle. Participants will be divided into two groups one group will receive three sessions of socio-aesthetic care during their first chemotherapy administration, provided by a socio-esthetician. The other group will receive supportive care available at the center, including psychology consultations, sophrology, art therapy, physiotherapy, and hypnosis, but will not have socio-aesthetic care. Patients will be seen six times at inclusion, during the first four chemotherapy courses, and at the end of chemotherapy. During the study, patients will complete anxiety questionnaires to measure their anxiety levels at various points. Researchers will assess changes in the State Anxiety score from the start of treatment through the third chemotherapy cycle, which lasts up to 21 days per cycle. Safety and adherence will be monitored throughout the chemotherapy period, with the total participation duration covering the chemotherapy cycles and follow-up visits.

Anxiolytic Effects of Socio-aesthetics in Cancer Patients Undergoing Chemotherapy